Skip to main content

Find Clinical Trials

Home
Conditions
Relapse

Clinical trial condition

Relapse

Explore clinical trials studying Relapse. Study availability and eligibility vary by location and protocol.

59 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Relapse trial results

Completed

A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients

NCT00752518

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Completed

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion

NCT00987987

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Hopital Henri Mondor Créteil, France

View Trial Details

Completed

Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma

NCT00306813

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Dept. of Internal Medicine II, University of Wuerzburg Würzburg, Bavaria, Germany

View Trial Details

Active, Not Recruiting

To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse

NCT07730619

Conditions: Biologic Agents, Disease Attributes, Influence Factors, +5 more
Locations: Dermatology Department of the First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Active, Not Recruiting

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

NCT05911321

Conditions: Aging, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States

View Trial Details

Active, Not Recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

NCT04176718

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

NCT04864626

Conditions: Disease Attributes, Eating Disorders, Feeding and Eating Disorders, +7 more
Locations: CHU de SAINT-ETIENNE Saint-Etienne, France

View Trial Details

Active, Not Recruiting

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

NCT00368082

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Childrens Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

The Effectiveness of 3 Orthodontic Fixed Retention Schemes on Post-treatment Stability and Gingival Recession

NCT05926934

Conditions: Disease Attributes, Orthodontic Retention, Pathologic Processes, +3 more
Locations: National and Kapodistrian University of Athens, School of Dentistry, Departments of Orthodontics Athens, Attica, Greece

View Trial Details